Medigen Biotechnology Corp.

  • About us
    • About us
    • History
    • Corporate milestones
    • Leadership
  • R&D
    • Clinical trials
    • R&D achievements
    • Collaborations
    • Subsidiaries
  • News
    • Press releases
    • Events
  • ESG
  • Investors
    • Corporate governance
    • Financials
    • Shareholder services
    • Material information
    • FAQs
  • Careers
    • Join us
    • Learning and development
    • Compensation and benefit
    • Sustainable talents
  • Contact
  • 繁體中文
  • 簡體中文
  • English

Material Information

  • 2025/08/13 Announcement on Election Results of Directors for Subsidiary TBG Diagnostics Ltd
  • 2025/08/13 Announcement on Election Results of Directors for Subsidiary TBG Diagnostics Ltd
  • 2025/08/11 Announcement of board meeting approved the consolidatedfinancial statements 2025Q2
  • 2025/08/05 The Progress Update of the New Drug under Development, OBP-301
  • 2025/08/04 Announcement of the date of the board of directors meeting for the second quarter of 2025 financial report
  • 2025/07/07 Announcement of Final Non-Prosecution DecisionRendered by the Taiwan High Prosecutors OfficeRegarding Company Executives
  • 2025/06/24 The Progress Update of the New Drug underDevelopment, OBP-301
  • 2025/06/06 Company has withdrawn its US FDA IND application for PhaseI/II human clinical trials of allogeneic natural killer cells (Magicell-NK)
  • 2025/06/05 Announcement of Important Resolutions fromthe 2025 Shareholders' Meeting of the Company
  • 2025/05/23 The Progress Update of the New Drug under Development, OBP-301
  • 1
  • 2
  • 3

About us

  • About us
  • History
  • Corporate milestones
  • Leadership

R&D

  • Clinical trials
  • R&D achievements
  • Collaborations
  • Subsidiaries

News

  • Press releases
  • Events

ESG

Investors

  • Corporate governance
  • Financials
  • Shareholder services
  • Material information
  • FAQs

Careers

  • Join us
  • Learning and development
  • Compensation and benefit
  • Sustainable talents

Contact

  • Privacy Policy
  • Cookie Policy
Copyright © 2025 Medigen Biotechnology Corp. All Rights Reserved.